BridgeMD
Compares treatment options for Club Foot
Official title Comparison of Radiological Outcome of Conventional vs Accelerated Ponseti Casting Technique for Treatment of Club Foot
ClinicalTrials.gov ID: NCT07554092
What this study is testing
- What it's testing
- Club foot (congenital talipes equinovarus) is a common birth deformity affecting 1-2 per 1,000 live births, with even higher rates in low-income countries. The standard treatment is the Ponseti method using weekly serial casts, but weekly visits for several weeks can be challenging for families in hot climates or with limited resources.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 5
You may be able to join if
- -Both gender with idiopathic club foot with age less than 6 months
You likely can't join if
- Syndromic club foot (e.g., associated with arthrogryposis, myelomeningocele, or other genetic syndromes)
- Previous treatment for club foot (either serial casting or surgical intervention)
- Any other significant congenital anomaly or medical condition that, in the opinion of the investigator, would interfere with treatment or follow-up
The study team makes the final eligibility decision.
Where it's taking place
- Peshawar, KPK, Pakistan
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 day to 5 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Peshawar, KPK, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.